Patients on hemodialysis and CKD patients not dialysis have a better hemoglobin response when treated with IV iron than with oral iron, but the difference in effect is stronger in hemodialysis patients, a meta-analysis showed.
The meta-analysis, by investigators at Tel Aviv University in Israel led by Benaya Rozen-Zvi, MD, examined data from 13 trials, of which seven included dialysis patients and six included CKD patients.
With respect to study limitations, the researchers noted that there was significant heterogeneity among the trials and follow-up was only two to three months.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.